Macrogenics reported $0 in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbvie ABBV:US $ 63522M 667M
Amgen AMGN:US $ 36010M 2788M
AstraZeneca AZN:LN 28805M 83M
Biogen BIIB:US $ 6275.7M 1.7M
Bristol Myers Squibb BMY:US $ 37450M 2155M
Cerulean Pharma CERU:US $ 0 0
Daiichi Sankyo 4568:JP Y 143067M 94M
Eli Lilly And LLY:US $ 15152.9M 193.5M
Epizyme EPZM:US $ 232.49M 379K
Genmab GEN:DC 356M 7M
Geron GERN:US $ 50.18M 0.35M
Gilead Sciences GILD:US $ 25183M 4M
Immunogen IMGN:US $ 0M 0M
Johnson & Johnson JNJ:US $ 28851M 1134M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Macrogenics MGNX:US $ 0 0
Merk MRK:US $ 30586M 104M
Mirati Therapeutics MRTX:US $ 0M 0M
Pfizer PFE:US $ 35656M 539M
Puma Biotechnology PBYI:US $ 97.38M 0.29M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 720.4M
Seattle Genetics SGEN:US $ 0M 0M
Xencor XNCR:US $ 0M 0M